#CancerTherapy is an active hashtag on Bluesky. In the last 30 days, 9 people shared 12 posts with it — around 0 a day. Activity is up 50% versus the previous week, peaking on Sep 17 with 2 posts.

Posts with #CancerTherapy

Nature Reviews Cancer

@natrevcancer.nature.com

over 1 year ago

FINALLY 🥁...our top most downloaded article of the year is…. 🥁🥁🥁 Why do patients with cancer die? By @tcox.bsky.social, Erik Sahai, et al. bit.ly/3WIyl... #metastasis #cancertherapy #cancermodels @crick.ac.uk @natureportfolio.bsky.social #NRCtop10of2024

bit.ly

Why do patients with cancer die? - Nature Reviews Cancer

In this Roadmap, Boire et al. consider the immediate causes of mortality in patients with cancer, a topic not often considered in either preclinical or clinical research, and provide recommendations for how we can stimulate research to advance our mechanistic understanding of these causes with a....

0 12 40

OncoDaily

@oncodaily.bsky.social

over 1 year ago

SPCC: Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond oncodaily.com/blog/227603 #BiomarkerTesting #Cancer #CancerResearch #CancerTherapy #CancerTreatmentAdvancements #ClinicalCharacteristics #HR+/HER2-MBC #MetastaticBreastCancer #OncoDaily #Health #Medicine

oncodaily.com

SPCC: Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond - OncoDaily

SPCC: Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond / biomarker testing, cancer, Cancer research, cancer therapy, cancer treatment

0 0 15

TRAstonDrs

@castltrastondrs.medsky.network

over 1 year ago

#Medsky🧪 #oncosky #publichealth p53 the protein in #Cancertherapy from the lab to the clinic.

The Conversation U.S. @us.theconversation.com

The protein #p53, known as the "guardian of the genome," plays a crucial role in preventing #cancer. When it malfunctions, tumors can form. Scientists are developing drugs to restore or mimic p53's function in cancer cells. A #biology researcher explains: 🧪 🩺 https://buff.ly/3EJ8Krw

1 5 14

OncoDaily

@oncodaily.bsky.social

over 1 year ago

Our recent review on Targeting the SMURF2-HIF1α axis - Wafik S. El-Deiry @weldeiry.bsky.social oncodaily.com/science/wafi... #Cancer #CancerTherapy #OncoDaily #Oncology #Medicine #SMURF2HIF1αAxis #Health

oncodaily.com

Wafik S. El-Deiry: Our recent review on Targeting the SMURF2-HIF1α axis - OncoDaily

Wafik S. El-Deiry: Our recent review on Targeting the SMURF2-HIF1α axis / cancer, cancer therapy, Connor Purcell, Emile Youssef, Frontiers, Gary L. Olson,

0 1 10

TRAstonDrs

@castltrastondrs.medsky.network

over 1 year ago

#Medsky🧪 #oncosky #cardioncology In real life Diagnosis and management of #Immunecheckpointinhibitors -induced #myocarditis following #cancertherapy www.sciencedirect.com/sci….

www.sciencedirect.com

Real life management of elevated troponin in patients treated with immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) have revolutionized the clinical outcomes of cancer. Nevertheless, their use may lead to myocardial injury. The 20…

0 3 8

Nature Reviews Cancer

@natrevcancer.nature.com

7 months ago

🥳 Our 3rd most downloaded #REVIEW in 2025: Acquired resistance in cancer: towards targeted therapeutic strategies #therapyresistance #cancertherapy @NatResCancer #NRCtop10of2025

dlvr.it

Acquired resistance in cancer: towards targeted therapeutic strategies - Nature Reviews Cancer

Acquired therapeutic resistance is a key contributor to cancer treatment failure, requiring new approaches to address its complex mechanisms. In this Roadmap, Soragni, Knudsen and colleagues discuss the mechanisms of acquired resistance and the models to better study it. Finally, they promote integration of biomarker-driven strategies and cutting-edge technologies to advance predictive and proactive prevention in cancer therapy.

0 2 8

Nature Reviews Cancer

@natrevcancer.nature.com

over 1 year ago

🥳 Our 2nd most downloaded article in 2024: Cancer therapy with antibodies by Paul, Gabelli, Ho, van Elsas et al. bit.ly/3EjrG... #drugdevelopment #cancertherapy #antibodytherapy @natureportfolio.bsky.social #NRCtop10of2024

bit.ly

Cancer therapy with antibodies - Nature Reviews Cancer

In this Review, Paul et al. provide an overview of therapeutic antibodies as an important modality in cancer therapy today. They summarize the different approaches used by antibodies to target cancer cells including those of immune checkpoint inhibitors, bispecific antibodies...

0 2 8

Helmholtz Munich

@helmholtzmunich.bsky.social

over 1 year ago

Engineering Smart Delivery for Gene Editors 🧬 👉 t1p.de/vmdc9 Researchers from #HelmholtzMunich & @tum.de created ENVLPE – a modular, virus-like system that delivers CRISPR/Cas9 tools into cells with unprecedented efficiency. #GeneEditing #CRISPR #CancerTherapy

0 2 7

Oliver Mortusewicz

@mortusewicz.bsky.social

over 1 year ago

🚀 Thrilled to share our latest review: "Uracil-induced replication stress drives mutations, genome instability, anti-cancer treatment efficacy, and resistance" 👉 doi.org/10.1016/j.mo... #CancerResearch #DNARepair #ReplicationStress #MolecularCell #GenomicInstability #CancerTherapy #Uracil

doi.org

Redirecting

2 1 7

Proceedings of the National Academy of Sciences

@pnas.org

over 1 year ago

Mysterious #NuclearSpeckles could unlock new answers in #KidneyCancer. In PNAS Journal Club: www.pnas.org/post/journal... #GeneRegulation #p53 #NuclearSpeckle #cancer #CancerTherapy

A kidney cancer cell nucleus is studded with aberrant nuclear speckles (orange). Normal healthy cells tend to have the speckles clustered toward the middle.

Image credit: Kate Alexander (Cold Spring Harbor Laboratory).

0 2 7

TRAstonDrs

@castltrastondrs.medsky.network

almost 3 years ago

MedSky🧪IDSky #Cancerresearch the evidence showing that the microbiota is an important determinant of both cancer treatment efficacy & treatment-induced acute & long-term toxicity . Role of the microbiota in response to and recovery from #cancertherapy www.nature.com/articles/s41...

Role of the microbiota in response to and recovery from cancer therapy

0 4 6

VIB Training & Conferences

@vibtrainconf.bsky.social

over 1 year ago

The VIB Conference on Tumor Heterogeneity, Plasticity, & Therapy is back (3rd edition) on Dec 10-12 in Leuven! Join us at #THPT25 for 2 days of pioneering research & discussions on #tumorbiology and #cancertherapy resistance. Be part of the conversation: vibbio.tech/3DLsomq. @vib-ccb.bsky.social